Edwards Lifesciences Corp (EW)

NYSE
Currency in USD
74.25
+0.27(+0.37%)
Real-time Data·
EW Scorecard
Full Analysis
Management has been aggressively buying back shares
EW is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
74.0174.74
52 wk Range
58.9395.25
Key Statistics
Edit
Prev. Close
73.98
Open
74.22
Day's Range
74.01-74.74
52 wk Range
58.93-95.25
Volume
703.19K
Average Volume (3m)
4.55M
1-Year Change
-16.43%
Book Value / Share
17.29
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EW Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
80.87
Upside
+8.91%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth
Show more

Edwards Lifesciences Company Profile

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Edwards Lifesciences Corp SWOT Analysis


TAVR Challenges
Edwards Lifesciences faces headwinds in its core TAVR business, revising growth outlook amid hospital workflow pressures and market competition
TMTT Growth Surge
Explore Edwards' success in Transcatheter Mitral and Tricuspid Therapies, offsetting TAVR slowdown and showcasing portfolio diversification
Market Positioning
Delve into Edwards' competitive landscape, analyzing its market leadership and strategies to maintain edge in evolving structural heart therapies
Future Prospects
Analysts project 10% revenue growth and double-digit EPS growth long-term, with price targets ranging from $70 to $90 per share
Read full SWOT analysis

Edwards Lifesciences Corp Earnings Call Summary for Q1/2025

  • Edwards Lifesciences Q1 2025 EPS of $0.64 beat $0.60 forecast; revenue grew 8% YoY to $1.41B, exceeding expectations
  • TAVR sales rose 5.4% to $1.05B; TMTT sales surged 60% to $115M, driving overall growth
  • Company raised 2025 sales guidance to $5.7-$6.1B, maintained full-year EPS guidance of $2.40-$2.50
  • Stock rose 2.9% in aftermarket trading; P/E ratio of 29.94x suggests potential undervaluation
  • Management highlighted innovation focus and hedging strategies to mitigate FX risks
Last Updated: 24-04-2025, 12:06 pm
Read Full Transcript

Compare EW to Peers and Sector

Metrics to compare
EW
Peers
Sector
Relationship
P/E Ratio
30.1x−8.7x−0.5x
PEG Ratio
0.150.150.00
Price/Book
4.3x3.6x2.6x
Price / LTM Sales
7.9x2.3x3.0x
Upside (Analyst Target)
8.1%80.6%51.9%
Fair Value Upside
Unlock−24.1%8.9%Unlock

Analyst Ratings

14 Buy
17 Hold
1 Sell
Ratings:
32 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 80.87
(+8.91% Upside)

Earnings

Latest Release
Apr 23, 2025
EPS / Forecast
0.64 / 0.60
Revenue / Forecast
1.41B / 1.40B
EPS Revisions
Last 90 days

EW Income Statement

FAQ

What Is the Edwards Lifesciences (EW) Stock Price Today?

The Edwards Lifesciences stock price today is 74.25.

What Stock Exchange Does Edwards Lifesciences Trade On?

Edwards Lifesciences is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Edwards Lifesciences?

The stock symbol for Edwards Lifesciences is "EW."

What Is the Edwards Lifesciences Market Cap?

As of today, Edwards Lifesciences market cap is 43.68B.

What Is Edwards Lifesciences's Earnings Per Share (TTM)?

The Edwards Lifesciences EPS (TTM) is 2.42.

When Is the Next Edwards Lifesciences Earnings Date?

Edwards Lifesciences will release its next earnings report on 23 Jul 2025.

From a Technical Analysis Perspective, Is EW a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Edwards Lifesciences Stock Split?

Edwards Lifesciences has split 3 times.

How Many Employees Does Edwards Lifesciences Have?

Edwards Lifesciences has 15800 employees.

What is the current trading status of Edwards Lifesciences (EW)?

As of 20 Jun 2025, Edwards Lifesciences (EW) is trading at a price of 74.25, with a previous close of 73.98. The stock has fluctuated within a day range of 74.01 to 74.74, while its 52-week range spans from 58.93 to 95.25.

What Is Edwards Lifesciences (EW) Price Target According to Analysts?

The average 12-month price target for Edwards Lifesciences is USD80.86793, with a high estimate of USD95 and a low estimate of USD61. 14 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +8.91% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.